Will PFE stock split soon?
Feb 23, 2021 · Another reason Pfizer has been down is that they've had some clinical setbacks. They really had high hopes for breast cancer drug Ibrance, and early breast cancer setting, and had a couple of ...
Why is PFE dropping?
May 14, 2021 · Pfizer ( PFE-2.25%) recently announced very good first-quarter results. Revenue and profits soared. ... I don't think we really knew what their costs were going to …
Why is Pfizer stock falling?
Pfizer, Inc. Analyst Report: Pfizer Inc. Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically ...
Should I buy Pfizer Inc. (PFE)?
Sep 22, 2020 · PFE is a strong candidate for covid-19 vaccine and ahead in race. #Trump announced "Vaccine will be available soon". Then what is stopping #PFE for moving up? As I mentioned in chart $36 to$39 price range is a strong resistance. I'm waiting for breakout. What do you think about this idea? Feel free to ask any questions regarding this idea. Like and comment …
There's still uncertainty about the big drugmaker's future COVID-19 vaccine revenue
Premium Investing Services
Pfizer ( PFE -1.09% ) recently announced very good first-quarter results. Revenue and profits soared. The big drugmaker even raised its full-year guidance. However, its share price barely moved.
COVID-19 shot interval can be extended to 8 weeks for some -U.S. CDC
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
Sanofi-Glaxo Vaccine May Threaten Pfizer, Moderna in Covid-19 Booster Market
Extending the interval between the first two doses of the most widely used COVID-19 vaccines in the country to eight weeks for young men can reduce the rare risk of heart inflammation, U.S. health officials said.
How many shots will Pfizer sell in 2021?
Sanofi and GlaxoSmithKline plan to submit their long-awaited Covid-19 vaccine for regulatory approval. Data suggest it's a contender against Pfizer and Moderna boosters.
Is Pfizer going to do a delta?
In its first-quarter earnings news release, BioNTech said it had secured contracts for 1.8 billion doses in 2021.
How many shots of Pfizer will be required in 2021?
Pfizer stock rose into breakout territory in late July after the company said it's planning to tackle the delta variant with a specific Covid vaccine. The company also is testing out a third dose of its BioNTech ( BNTX )-partnered Covid vaccine as a booster shot. But U.S. officials still aren't sold on whether boosters will be needed.
Can Pfizer be refrigerated?
The companies intend to manufacture up to 50 million doses this year, and as much as 1.3 billion doses in 2021. Two shots of the vaccine will be required per person. While Pfizer stock was up by almost 8% following the news, we think it’s unlikely that the vaccine will meaningfully move the needle for the company for multiple reasons.
Is Pfizer working with Biontech?
On the other hand, vaccines being developed by the likes of Oxford- AstraZeneca, Novavax, and others can be held at regular refrigerated temperatures. This could potentially limit the use of Pfizer’s vaccine to clinics and hospitals that have the appropriate storage facilities.
Why did Pfizer's revenue decline?
Pfizer (PFE) is working with German partner BioNTech on a Covid-19 vaccine. The company is likely to have efficacy data from late-stage trials available shortly. The company could supply about 40 million doses in the United States in 2020 if the data is positive and regulators approve the vaccine. The stock is down by about -7.6% this year.
How much will Pfizer sell in 2021?
Though the revenues declined 3.5% from $53.6 billion to $51.8 billion, it was due to the de-consolidation of its consumer healthcare business. Pfizer’s Net Margins expanded 51% from 21% to 31%, primarily due to a one-time gain of $8 billion from the consumer healthcare transaction.
What is Pfizer's net margin?
In fact, Pfizer’s Covid-19 vaccine peak sales are estimated to be as high as $3.5 billion in 2021. This is likely to bolster the revenue growth rate of the company in the near term – leading to stock price growth. PFE stock has rallied from $27 to $39 off the recent bottom compared to the S&P which moved 61% over the same time period.
What is the restructuring of Pfizer?
The Net Margins stood at 25% for the first nine month period in 2020. Finally, Pfizer’s P/E ratio contracted from 23x in 2018 to 13x in 2019. While the company’s P/E is still at around 13x trailing earnings, it could see further expansion given the market share gains for some of its drugs, including breast cancer treatment Ibrance, ...
Is Pfizer upside?
The restructuring will allow the company to focus on the high growth Biopharma segment, which includes oncology drugs, such as Ibrance, vaccines, such as Prevnar, and Pfizer’s newly approved biosimilars for some of the blockbuster drugs, including Humira and Avastin.
